RX South DBA RX3 Compounding Pharmacy LLC 10 23 14 FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its Compounded "semaglutide" is not FDA approved semaglutide.com